Phibro Animal Health Overview
- Founded
-
1946
- Status
-
Public
- Employees
-
1,725
- Stock Symbol
-
PAHC
- Investments
-
7
- Share Price
-
$19.59
- (As of Friday Closing)
Phibro Animal Health General Information
Description
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the US and other international countries.
Contact Information
Website
www.pahc.com
Formerly Known As
Philipp Brothers Chemicals
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
- Glenpointe Centre East, 3rd Floor
- 300 Frank West Burr Boulevard, Suite 21
- Teaneck, NJ 07666
- United States
+1 (201) 000-0000
Phibro Animal Health Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.59 | $19.13 | $17.28 - $30.39 | $793M | 40.5M | 90.5K | $1.45 |
Phibro Animal Health Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 30-Jun-2021 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 |
|---|---|---|---|---|
| EV | 1,147,299 | 1,490,225 | 1,370,784 | 1,529,562 |
| Revenue | 907,274 | 833,350 | 800,354 | 827,995 |
| EBITDA | 120,116 | 110,213 | 100,709 | 110,845 |
| Net Income | 58,809 | 54,385 | 33,552 | 54,713 |
| Total Assets | 916,181 | 841,325 | 784,100 | 726,671 |
| Total Debt | 455,684 | 426,706 | 410,722 | 326,175 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Phibro Animal Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Phibro Animal Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactur
Pharmaceuticals
Teaneck, NJ
1,725
As of 2021
00000
000000000
00000
000000
nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
000000000000000
Lagos, Nigeria
00
As of 0000
000000
re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui offic
000000000000000
Mumbai, India
0000
As of 0000
Add Comparison
Phibro Animal Health Competitors (15)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlaxoSmithKline Consumer Nigeria | Corporation | Lagos, Nigeria | 00 | |||
| 000000 00000 | Corporation | Mumbai, India | 0000 | |||
| 0000000 0000000000 | Corporation | Overland Park, KS | 00 | 000.00 | 000000000 | 000.00 |
| 00000 (000000) | Corporation | Sao Paulo, Brazil | ||||
| 00000000 00000 | Corporation | Mumbai, India | 00 | 00.000 | 00000000000 | 00.000 |
Phibro Animal Health Patents
Phibro Animal Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210229139-A1 | Method and composition for pulse dose cleaning of process streams | Pending | 27-Jan-2020 | 00000000000 | |
| EP-3745865-A1 | Composition and method for reducing fungal infections in crops | Pending | 01-Feb-2018 | 00000000 | |
| EP-3745865-A4 | Composition and method for reducing fungal infections in crops | Pending | 01-Feb-2018 | 00000000 | 0 |
| US-20200296972-A1 | Composition and method for reducing fungal infections in crops | Pending | 01-Feb-2018 | 00000000 | |
| US-20190230935-A1 | Composition and method for reducing fungal infections in crops | Granted | 01-Feb-2018 | A01N63/00 |
Phibro Animal Health Executive Team (14)
Phibro Animal Health Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000 | Self | Board Member | 000 0000 |
| 000000 00000000 | Phibro Animal Health | Board Member & Executive Vice President | 000 0000 |
| 000000 0000000 00.0 | Phibro Animal Health | Board Member | 000 0000 |
| 0000 00000000 | Phibro Animal Health | Chief Executive Officer & Chairman | 000 0000 |
| 00000000 00000000 | Phibro Animal Health | Board Member & General Manager | 000 0000 |
Phibro Animal Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Phibro Animal Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Phibro Animal Health Investments & Acquisitions (7)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 01-Aug-2019 | 0000000000 | 000.00 | Biotechnology | 0000 0000 |
| 00000 | 06-Dec-2018 | 0000000000 | Biotechnology | 00'0000 0 | |
| 000000 | 11-Sep-2017 | 0000000000 | Food Products | 00000 000 | |
| 000 000000000 | 25-Jan-2016 | 0000000000 | 000.00 | Pharmaceuticals | 0000 0000 |
| Aqua-Vet | 20-Jan-2014 | Buyout/LBO | Aquaculture | 00000 000 |
Phibro Animal Health Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 00000000000 | Biotechnology | Sarasota, FL | 0000 |